Jonathan J. Fleming
Jonathan J. Fleming has served as a Chairman of our Board since inception. Mr. Fleming is the Managing Partner of Pimlico Pond Investments, a venture capital investment firm based in Newton MA. From 2015 to 2018 Mr. Fleming was the CEO of Q-State Biosciences, a private neuroscience company based on technologies licensed from Harvard University located in Cambridge MA. From 1996 to 2015 Mr. Fleming was the Managing General Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology-based investments which invested more than $1 billion in over 100 early stage life science companies. In 1994 Mr. Fleming was a co-founder and General Partner of Medica Venture Partners, one of the first early stage healthcare venture capital firms in Israel which co-invested frequently with his primary fund Oxford. He is currently the Chairman or an active Director in five additional private companies. During his career Mr. Fleming has served on numerous boards of private and public companies and has taken numerous companies through an IPO or M&A process. From 2002 to the present Mr. Fleming has been a Senior Lecturer teaching a graduate level class on strategy in the life science industry at the MIT Sloan School of Business. From 2005 to the present Mr. Fleming has been a member of the executive board as Treasurer and head of the Audit Committee of NEHI, a health care policy think tank based in Boston MA. He holds a Master’s degree in Public Administration from Princeton University and a B.A. in Political Science from the University of California, Berkeley.